The purpose of the study is to determine the safety and effectiveness of dilation and evacuation for surgical abortion as compared to medical abortion
All patients with a gestational age between 13-20 weeks are fully counseled on the risks and benefits and given the option of medical or surgical abortion. Those who choose medical abortion receive mifepristone 200 mg on day 1 and are appointed to return to SPHMMC 24-48 hours later for admission and misoprostol administration. Those who chose surgical abortion are given mifepristone 200 mg with or without laminaria and appointed to return the next day for surgical abortion.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
279
Abortion is termination of pregannacy by evaccuating the uterus using either medical or surgical technique
Saint Paul's Hospital Millennium Medical College
Addis Ababa, Ethiopia
Composite complication rate
Presence of one of the following complications: bleeding requiring observation, genital tract lacerations requiring repair, need for additional intervention to complete the abortion procedure, and one or more symptoms of pelvic infection
Time frame: During the abortion procedure and within 2 weeks post procedure
Other serious maternal complications
Continued bleeding for more than two weeks, additional major surgery (laparotomy), and death.
Time frame: During the abortion procedure and within 2 weeks post procedure
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.